Background and Purpose-Increased blood-brain barrier (BBB) permeability, brain edema, and hemorrhage are important consequences of cerebral venous sinus thrombosis (CVST). The objective of this study was to define the role of the protein C pathway in the BBB permeability and edema elicited by experimental CVST. The role of neutrophil recruitment was also evaluated. Methods-Edema, BBB permeability, leukocyte-endothelial cell adhesion (LECA) and inflammatory cytokine levels were monitored in a murine model of CVST. The role of activated protein C (APC) was assessed in wild type mice (WT) receiving APC neutralizing antibody and in endothelial protein C receptor overexpressing mice (EPCR-tg). Neutrophil involvement was evaluated using an anti-CD18 antibody (Ab) and antineutrophil serum. Results-Brain edema and increases in BBB permeability and LECA were noted 48 hours after CVST. APC immunoblockade exacerbated these responses, while EPCR-tg exhibited blunted responses, as did WT treated with either antineutrophil serum or the CD18 Ab. 
C erebral venous sinus thrombosis (CVST) is frequently associated with coagulation disorders (eg, protein C [PC] deficiency) and systemic inflammatory diseases (eg, sepsis). 1 Blood-brain barrier (BBB) dysfunction and the resultant edema and hemorrhage, and an elevated intracranial pressure have all been implicated in the injury that accompanies CVST in human brain. 2, 3 Experimental models of CVST have also revealed that BBB disruption and infiltration of inflammatory cells occurs in proximity to the site of thrombosis. 4 -7 Although severe brain edema is known to be a poor prognostic indicator for CVST, the mechanisms that elicit this deleterious response remain undefined. It is also unclear whether chemical signals generated during the thrombogenic response or the resultant inflammatory response contributes to the brain edema and BBB alterations after CVST.
Activated PC (APC) is produced by endothelial cells via the interaction of PC with thrombin-thrombomodulin complex and the endothelial cell protein receptor (EPCR). 8 -10 The pathophysiological role of the PC pathway in CVST may extend beyond the thrombogenic process. APC has recently been shown to exert antiinflammatory, vasculoprotective, and neuroprotective effects in animal models of ischemic and hemorrhagic stroke. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Although CVST is considered a form of stroke, ischemia does not appear to be an initiating event in this condition. 10 Hence, it remains unclear whether APC can exert similar vasculoprotective effects in the brain after CVST.
The objective of this study was to determine whether genetic or immunologic manipulation of the PC pathway alters the brain injury response to CVST. To this end, brain water content (edema), BBB permeability, and leukocyte-endothelial cell adhesion were monitored at 3 and 48 hours after the induction of CVST in mice. Our findings support a role for the PC pathway and inflammatory cells in the brain edema associated with CVST.
Materials and Methods

Animal Preparation
Male C57BL/6 (WT; nϭ151, Jackson Laboratories, Bar Harbor, Me) and transgenic mice overexpressing EPCR (EPCR-tg; nϭ11) were used. The EPCR-tg (backcrossed into WT mice) exhibit normal size, weight, viability, fertility, blood cell count, and chemistries as described. 21 EPCR protein levels in all organs of the transgenic mice are at least 8-fold higher than in WT. All experimental procedures involving the use of animals were reviewed and approved by the Institutional Animal Care and Use Committee of LSU Health Sciences Center and performed according to the criteria outlined by the National Institutes of Health.
Induction of Cerebral Venous Sinus Thrombosis
Each mouse was anesthetized by intraperitoneal injection of ketamine hydrochloride (100 mg/kg) and xylazine (10 mg/kg). A longitudinal craniotomy (5 mm ϫ1 mm) was performed between the bregma and lambda, producing a narrow window lying just above the superior sagittal sinus (SSS). Previously reported models of SSS thrombosis used filter paper strips soaked with FeCl 3 that were placed over the SSS. 4, 6, 22, 23 We found that it is difficult to prevent direct contact of the filter paper with the brain surface, which results in FeCl 3 -induced necrosis and inflammation in adjacent cortical tissue. In this study, SSS thrombosis was induced without injury to cortical tissue by direct topical placement of a 5-mm length of 6-0 silk thread soaked with 20% FeCl 3 (Sigma-Aldrich) on the sinus for a 5-to 10-minute period in the absence of light. At the 5-minute period, the field was washed with warmed normal saline after removing the thread and checked thrombus formation. If the initial procedure did not produce enough thrombus for complete occlusion (occurred in approximately 30% to 50% of mice), 5 minutes more FeCl 3 attachment was repeated (which yielded an occluding thrombus in 100% of mice). In sham animals, a saline-soaked silk thread was placed topically on the SSS. Cerebral blood flow in the parietal cortex was measured before and after CVST induction using a laser Doppler flowmeter (ML191 Blood Flow Meter, AD Instruments). On completion of the thrombosis (or sham) protocol, the window was closed and the animal was allowed to recover in its cage, where it had free access to food and water. Two days later, the mice were studied (as described below) under anesthesia and then euthanized by anesthetic overdose after data/sample collection. Preliminary experiments confirmed that blood pressure and blood gases were not affected by the surgical procedure.
Experimental Protocols
Time-dependent changes in brain edema and inflammation were monitored in mice subjected to CVST (or a sham procedure) and then allowed to recover for either 3 or 48 hours. Brain edema, BBB permeability, leukocyte-endothelial cell adhesion, and cytokine levels were monitored. The role of the PC pathway was evaluated (at 48 hours after CVST induction) in 3 groups: (1) control WT (WT-cont), (2) WT receiving (i.v.) 40 g of rat antimouse APC monoclonal antibody (MPC1609; Oklahoma Medical Research Foundation) 20 minutes before CVST induction (WT-APC Ab), and (3) EPCR-tg. The contribution of leukocytes to the increased BBB permeability and brain edema was evaluated (at 48 hours after CVST induction) in WT receiving either a rat antimouse CD18 monoclonal antibody (GAME-46; BD Biosciences; CD18Ab) or mouse antineutrophil serum (RB6 -8C5, Accurate Chemical; ANS). Two doses (30 g each) of the CD18Ab were administered intravenously 15 minutes before CVST induction and 24 hours thereafter (WT-CD18Ab). The blocking effect of the CD18Ab was verified by monitoring leukocyte adhesion in treated versus untreated mice. The ANS was administered (150 g) intraperitoneally 24 hours before CVST to deplete circulating neutrophils 24 (WT-ANS). Neutrophil depletion (from 4600Ϯ1174 to 440Ϯ167/mm 3 cells) was verified by counting neutrophils in peripheral blood before ANS injection and immediately before the experiment. These groups were compared with the WT-control group. To address potential nonspecific effects of antibody administration, 7 WT-control mice received an equal dose of control antibody (Rat IgG1 Isotype Control, R & D Systems). In these mice, brain water content (78.77Ϯ0.06 versus 78.87Ϯ0.13) and survival rate did not differ from WT-control mice not receiving the control antibody.
Brain Water Content
At 48 hours after CVST induction, the brain was removed and stripped of the dura mater, brain stem, and cerebellum. The cerebrum was placed into a 70°C oven for 4 days. The water content was determined from the formula ([wet brain weight Ϫ dry brain weight]/ wet brain weight) and expressed as percent.
Intravital Videomicroscopy
The cerebral microcirculation was examined with an upright fluorescent microscope for measurements of BBB permeability and leukocyte-endothelial cell adhesion. The vessels studied were approximately 3 mm from the site of SSS thrombosis. The microscope was equipped with filter cubes for green and blue fluorescence. The microscopic images were captured with a video recorder timer (Panasonic Japan, WJ-810; Panasonic Japan).
BBB Permeability
A modification of the procedure of Yuang et al was used to quantify BBB permeability, with FITC-dextran (40 kDa; Sigma-Aldrich) as the tracer molecule. 25, 26 A cranial window (3 mm diameter) was created 3 mm lateral and 2.5 mm posterior to the bregma. The dura mater was removed, the brain surface was immersed in artificial CSF, and the window closed with a cover slip. FITC-dextran was injected into the femoral vein (10 mg/mL, 1 mL/kg), and 30 s thereafter the brain microvasculature was illuminated for 30 s, followed by 1-s illumination every 30 s for 4 minutes and then 1 s every minute for 10 minutes (to minimize the photochemical injury).
Images of FITC fluorescence were recorded, transferred to a personal computer with ImageJ software (National Institutes of Health), and analyzed off-line. A 10ϫ50-m rectangular region of interest (ROI) was selected within a venule and a corresponding ROI was selected outside the vessel, within 10 m of the vessel wall. The ROI values used to estimate BBB permeability in each animal were averaged from 3 vessels. Permeability was calculated using the formula:
where, I t is tissue fluorescence intensity, I v is initial fluorescence intensity within the vessel, V/S is the ratio of vessel volume and surface area, and H ct is hematocrit (set at 45%). After subtracting the rate of change of the background intensity, dI t /dt was determined from the slope of the tissue pixel intensity versus time curve obtained between 30 s and 5 minutes after tracer injection.
Leukocyte-Endothelial Cell Adhesion
On completion of the FITC-dextran permeability measurements, the mice received 50 L of 0.02% rhodamine 6G (Sigma Chemical) to label circulating leukocytes. Leukocyte-endothelial cell adhesion was observed in randomly selected venular segments (25 to 45 m diameter and 100 m length). Adherent leukocytes remained stationary within the venule for a period Ն30 s and were normalized to venule surface area.
Cytokine Levels
A cytometric bead array (CBA Mouse Inflammation Kit, BD Biosciences) was used to measure the concentration of interleukin-12, TNF-␣, interferon-gamma, monocyte chemoattractant protein-1 (MCP-1), interleukin-10 (IL-10), and interleukin-6 in plasma and brain tissue. Samples were collected at either 3 or 48 hours after CVST induction or a sham procedure. A group of mice not exposed to any surgical procedure (control) was also evaluated. Cytokine concentrations in the sham and CVST groups were expressed as pg/g (brain weight) or pg/mL (plasma) and normalized to the values measured in the control (no surgery) group.
Statistical Analyses
All data were expressed as meanϮSE. Statistical difference (PϽ0.05) between the different groups was determined by a 1-way analysis of variance (ANOVA) with the Fisher post hoc test or Student t test. A 2-way ANOVA was used to determine time-dependent differences in cytokine concentration. Mortality rates were compared with a 2 test. All analyses were performed using Stat View 4.5 software (Abacus Concepts Inc).
Results
Blood Flow Changes
The reduction of cerebral blood flow after the induction of CVST in WT (nϭ5) was 9.4Ϯ5.0%, which was not statistically significant from the pre-CVST value. Figure 1 summarizes the time-dependent changes in brain water content, BBB permeability, and adherent leukocytes in cerebral venules of WT subjected to either CVST or a sham procedure (controls). At 3 hours after CVST, brain water content ( Figure 1A ) and BBB permeability ( Figure 1B) were not significantly different from control values. However, a large increase in the number of adherent leukocytes ( Figure  1C ) was noted in venules of CVST exposed mice. At 48 hours, significant brain edema was detected and there was a corresponding increase in BBB permeability. The number of adherent leukocytes remained significantly elevated at 48 hours.
Time-Dependent Changes in Brain Water Content and Inflammation
Of the 6 cytokines monitored in brain tissue and plasma after CVST, only MCP-1 and IL-10 levels in brain tissue were significantly altered. MCP-1 concentration in brain began to rise (compared to sham controls; Figure 2A) and IL-10 level began to fall at 3 hours after CVST ( Figure 2B ). Plasma cytokines levels were not altered by CVST. Figure 3 compares the changes in brain water content, BBB permeability, and number of adherent leukocytes observed at 48 hours after CVST between WT-cont, WT-APC Ab, and EPCR-tg. The EPCR-tg exhibited a significant attenuation of CVST-induced brain edema ( Figure 3A) . Treatment with the APC Ab tended to augment brain water content, although this did not achieve statistical significance. The WTϩAPC Ab group also exhibited a mortality rate of 38.5% (5 of 13 mice), whereas all other CVST groups exhibited 0% mortality, with 8 of 8 (WT-cont) and 6 of 6 (EPCR-tg) surviving (PϽ0.05).
Role of the PC
The increased BBB permeability elicited by CVST was greatly exaggerated in mice treated with the APC Ab and significantly attenuated in the EPCR-tg ( Figure 3B) . A similar pattern was noted for recruitment of adherent leukocytes in cerebral venules (ie, increased adhesion with APC Ab), and an attenuated response in EPCR-tg ( Figure 3C ).
Role of Leukocytes
The data from the different experimental groups were used to examine the relationship between BBB permeability and 
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leukocyte adherence in cerebral venules (Figure 4 ). This analysis revealed a significant positive correlation between the 2 variables, suggesting that the protective effects of the APC-directed interventions on BBB permeability may relate to their ability to blunt leukocyte adhesion. To directly address this possibility, we determined whether interfering with leukocyte adhesion or rendering mice neutropenic altered the development of brain edema and increased BBB permeability at 48 hours after induction of CVST ( Figure 5 ). These experiments indicate that both CD18 immunoneutralization and neutropenia were effective in reducing CVSTinduced brain edema ( Figure 5A ) as well as the BBB dysfunction ( Figure 5B ).
Discussion
A major life-threatening consequence of CVST is cerebral edema. 27 The edema is believed to result from an elevated intravascular pressure that occurs secondary to sinus thrombosis, with the combination of an increased capillary hydrostatic pressure and pressure-induced BBB disruption directly mediating the brain swelling. In view of the extensive collateral circulation in the cerebral venous system, it is possible that other mechanisms may also account for the responses to CVST. In this study, we provide evidence suggesting that inflammatory cell recruitment, linked to an impaired PC pathway, contributes the edemagenic responses to CVST. Previous studies have demonstrated brain edema, increased BBB permeability and intracranial pressure, and neutrophil infiltration in rodent models of CVST. 4 -6,28 Some CVST models have yielded evidence for significant perfusion deficits in the brain, 29 -31 leading to speculation that the pathogenesis of CVST may parallel that of ischemic stroke. However, measurements of cerebral blood flow in our mouse model of CVST revealed small and seemingly inconsequential changes in brain perfusion, especially when compared to the 90% reduction in brain perfusion during occlusion of the middle cerebral artery in mice. 32 Despite the unaltered brain perfusion, we detected significant brain edema, as well as increased BBB permeability and leukocyte-endothelial cell adhesion at 48 hours following the induction of CVST. At 3 hours after CVST, there was no evidence for edema or BBB disruption, but increased leukocyte adhesion with elevated MCP-1 and lower IL-10 concentrations in brain tissue were detected, suggesting that the tissue assumes an inflammatory phenotype prior to the edemagenic response.
APC has been shown to exert significant antiinflammatory and neuroprotective effects in animal models of ischemic and hemorrhagic stroke. 11,13-15,18 -20 Here, we provide evidence that implicates APC in the inflammation and edemagenic responses to experimental CVST. Overexpression of EPCR conferred protection against the leukocyte recruitment, BBB disruption, and brain edema elicited by CVST, whereas immunoblockade of endogenous APC produced the opposite responses.
Several previous studies have demonstrated a link between increased vascular permeability and leukocyte-endothelial cell adhesion. 33, 34 Our CVST model revealed a significant positive correlation between BBB permeability and the number of adherent leukocytes, suggesting that the CVSTinduced BBB disruption may be dependent on the adhesion of leukocytes or vice versa. A dependency of BBB permeability on leukocyte adhesion is supported by our observations that either inhibiting leukocyte adhesion (CD18 mAb) or inducing neutropenia (ANS) largely prevented the increased BBB permeability and brain edema observed 48 hours after the induction of CVST. Although the mechanism for the barrier protective effect of APC remains unclear, our findings, coupled to the observed relationships between BBB permeability and leukocyte adhesion after CVST in animals subjected to endogenous APC manipulation, suggest that APC may exert its protective effect via modulation of leukocyteendothelial cell adhesion. This is consistent with evidence that the APC-EPCR complex is involved in the regulation of P-selectin expression. 35 However, in vitro studies indicate that APC can directly blunt BBB permeability responses via PAR-1 activation, 12, 17, 18 suggesting multiple modes of action of APC.
In conclusion, the results of this study provide evidence that the inflammatory and edemagenic responses in brain tissue after CVST are linked to alterations in the PC pathway and leukocyte-endothelial cell adhesion. Our findings suggest that APC or anti-leukocyte adhesion therapies may be useful in the management of CVST patients with a poor prognosis related to severe cerebral edema.
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